TBpreventive treatment is an affordable intervention that can prevent families from sliding into poverty and preserve the health and economy of whole communities.
WHO anticipates that as new and safer drugs come onto the markets, and as prices fall, it will become a highly-cost effective way to save millions of lives.
WHO works closely with Member States including the US Government and technical and funding partners such as UNITAID to enhance access to shorter TB preventive treatment regimens.
UNITAID-supported projects such as IMPAACT4TB and Cap-TB projects enabled by WHO with partners in Brazil, Cambodia, Cameroon, Côte d’Ivoire, Democratic Republic of Congo, Ethiopia, Ghana, India, Indonesia, Kenya, Lesotho, Malawi, Mozambique, South Africa, Uganda, United Republic of Tanzania and Zimbabwe are leading the way.
The new treatment options are also now more affordable, thanks to the significant price drop of rifapentine - a key drug - facilitated recently by UNITAID, the Global Fund to Fight AIDS, Tuberculosis and Malaria and global biopharmaceutical company Sanofi, along with forthcoming arrangements underway with generic manufacturers.
6598
有关该指南的更多情况
MORE ABOUT THE GUIDELINES
6599
世卫组织新的综合指南随附了一份业务手册，可帮助指导各国逐步采用结核病预防治疗并扩大规模。
The new consolidated WHO guidelines come with an operational handbook to help guide countries step-by-step as they take TB preventive treatment to scale.
6600
这包括从预防结核病的需求创造到规划的监督和监测方面指导如何确定重点并进行投资。
This includes guidance on how to prioritize and invest from demand creation for TB prevention to supervision and monitoring of the programme.